Inflammasome components of the NLRP3 are expressed in both the central and peripheral nervous system according to clinical and preclinical study, for example, HD patients’ PBMCs express higher levels of NLRP3 than healthy controls (Glinsky, 2008). Here, NLRP3 is linked to Huntington disease.